Geneva, Oct. 9 -- International Clinical Trials Registry received information related to the study (ChiCTR2600133452) titled 'Effect of Oliceridine on Postoperative Gastrointestinal Function in Patients after Colonic Surgery:' on Sept. 28.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Jiangsu Province Hospital (The First Affiliated Hospital with Nanjing Medical University)
Condition:
Postoperative Gastrointestinal Function and Recovery Quality
Intervention:
Sufentanil group:Sufentanil 7.5 µg IV 15 min before end of surgery. Postoperative PCIA: Sufentanil 2 µg/kg in 100 mL normal saline
background 2 mL/h
bolus 2 mL
lockout 30 min
hourly limit 6 mL. Pump removed at 48 h postoperatively.
Oliceridi...